- Monday, April 20, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Influenza Diagnostics Market by Test Type (Traditional Diagnostic Tests (RIDT, Viral Culture, DFA, and Serological Assays), Molecular Diagnostic Tests(RT-PCR, Isothermal Nucleic Acid Amplification Tests and Others) and Others), By End-User (Hospital, Clinical Laboratories , Research Centers and Point Of Care Testing Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)
Global Influenza Diagnostics Market Overview:
Influenza is an acute respiratory disease caused by the influenza virus. It has the characteristics of strong infectivity and fast spread. Winter and spring are the high season of the influenza epidemic and spread. The population is generally susceptible to influenza. Among them, children <5 years old, older people ≥65 years old, pregnant and perinatal women, those with chronic underlying diseases or immune-compromised people are at high risk. For children under two years of age, serious complications occur from time to time, which requires the attention of parents and medical workers.
In the flu-prone season, there are still other pathogens that cause respiratory tract infections, especially the clinical manifestations of some children, which may be typical. Therefore, in addition to the need to pay attention to the clinical manifestations of children, the identification of influenza, common cold, bacterial pneumonia, etc. is essential. Effective pathological diagnosis methods can also help clinical differential diagnosis.
Global Influenza Diagnostics Market Insights
The global Influenza diagnostics market projected to grow at a CAGR of over 7.5% during the forecast period, 2020-2027. The major factors attributed to the rising prevalence of influenza and the surge in demand for faster diagnostics. Additionally, the initiatives by government bodies such as WHO and CDC to control and prevent influenza estimated to propel the growth of the global Influenza diagnostics market in the upcoming periods. Moreover, the surge in research and development, technological advancements in diagnostic tests, and growing demand for influenza diagnosis will accelerate the growth of the global Influenza diagnostics industry in the future period. At present, the etiological diagnosis methods of influenza mainly include virus antigen detection, nucleic acid detection, culture separation, and serotype detection.
Furthermore, the increasing demand for point-of-care diagnostics coupled with growing approvals of influenza diagnostic products by regulatory authorities will spur the growth Influenza diagnostics industry. Also, the increasing geriatric population and chronic diseases, coupled with the government initiatives to counter influenza and the emergence of technologically advanced influenza diagnostic is projected to foster the growth of the Influenza diagnostics market. The growing prevalence of influenza and related chronic diseases coupled with the increasing demand for early diagnosis and control of influenza will trigger the growth of influenza diagnostics market share.
Growth Driver
Increasing prevalence of influenza
Influenza is an acute respiratory infection caused by the influenza virus. It is also a highly contagious disease that spreads quickly. It is mainly spread through droplets in the air, contact between people, or contact with contaminated items. The disease is caused by the influenza virus and can be divided into three types: A (A), B (B), and C (C). According to WHO, yet seasonal influenza kills up to 650 000 people every year.
Growing government initiatives to counter influenza
WHO has been mandated by a series of World Health Assembly resolutions to provide the Member States with guidance and technical support regarding influenza. These are WHA 56.19: Prevention and control of influenza pandemics and annual epidemics; WHA 58.5: Strengthening pandemic influenza preparedness and response; and WHA 60.28: Pandemic influenza preparedness: support in sharing the influenza viruses and access to vaccines and other benefits.
Increasing prevalence of chronic diseases
According to WHO, the burden of chronic diseases is rapidly increasing worldwide. In 2001, chronic diseases contributed approximately 60% of the 56.5 million world population, and reported deaths were 46% of the global burden of disease. WHO predicted the proportion of the burden of NCDs is expected to increase to 57% by 2020.
WHO also stated that, by 2020, chronic diseases would account for almost three-quarters of all deaths worldwide, in which 71% of deaths due to ischaemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries.
Test Type Segmental Analysis
Based on end-user, the global influenza diagnostics market segregated into hospitals, Clinical Laboratories, research centers, and point of care testing centers. The hospital segment held a lucrative share in 2019 and projected to dominate the global Influenza Diagnostics market by 2027. It is due to regular epidemics, their easy accessibility, and a generally higher preference for this establishment. Additionally, influenza is complex and requires a technologically advanced product.
The point of care testing centers will be the fastest-growing segment in the forecast period. It is owing to ease of use and usage by anyone and not requiring much expertise, except basic operational knowledge and advent of technological advancements in POCT, the reliance of the public and physicians on these tests has significantly increased.
End-User Segmental Analysis
Based on end-user, the global influenza diagnostics market segregated into hospitals, Clinical Laboratories, research centers, and point of care testing centers. The hospital segment held a lucrative share in 2019 and projected to dominate the global Influenza Diagnostics market by 2027. It is due to regular epidemics, their easy accessibility, and a generally higher preference for this establishment. Additionally, influenza is complex and requires a technologically advanced product.
The point of care testing centers will be the fastest-growing segment in the forecast period. It is owing to ease of use and usage by anyone and not requiring much expertise, except basic operational knowledge and advent of technological advancements in POCT, the reliance of the public and physicians on these tests has significantly increased.
Region Segmental Analysis
Based on geography, the global Influenza Diagnostics market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s share in the Influenza Diagnostics market by 2027. Growing prevalence of influenza, the surge in the number of influenza screening tests performed in this region results in high growth. Additionally, high technological advancements in the region, along with increasing healthcare spending by USA governments, will drive the North America region.
The Asia Pacific a prominent share of the Influenza Diagnostics market and projected to remain dominant by 2027. It is due to higher disease burden, the surge in the rate of population, rising initiatives to control the disease rate, and growing concern, and the countries are actively involved in taking preventive measures to counter the incidence of the disease.
Competitor Analysis
Companies such as F. Hoffmann-La Roche AG, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Hologic, Becton, Dickinson, and Company, DiaSorin S.p.A, Luminex Corporation, Meridian Bioscience, GenMark Diagnostics, SA Scientific, Sekisui Diagnostics, bioMérieux SA, Danaher Corporation, Siemens Healthineers, Tecan Trading AG, ELITech, Mast Group, Altona Diagnostics, Coris BioConcept, and Genome Diagnostics are the key players in the global influenza diagnostics market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global Influenza Diagnostics manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to Influenza Diagnostics
- Regulatory bodies
- Suppliers
- Retailers
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Test Type
- Traditional Diagnostic Tests
- RIDT
- Viral Culture
- DFA
- Serological Assays
- Molecular Diagnostic Tests
- RT-PCR
- Isothermal Nucleic Acid Amplification Tests
- Others
- Others
By End-User
- Hospital
- Clinical Laboratories
- Research Centers
- Point Of Care Testing Centers
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Global Influenza Diagnostics Market
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Technological Landscape
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Economic Factor Analysis
- Global Influenza Diagnostics Market Overview
- Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Market Share & Forecast, 2016-2027
- By Test Type
- Traditional Diagnostic Tests
- RIDT
- Viral Culture
- DFA
- Serological Assays
- Molecular Diagnostic Tests
- RT-PCR
- Isothermal Nucleic Acid Amplification Tests
- Others
- Others
- Traditional Diagnostic Tests
- By End-Users
- Hospital
- Clinical Laboratories
- Research Centers
- Point Of Care Testing Centers
- By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- By Test Type
- Demand
- Market Size & Forecast, 2016-2027
- North America Influenza Diagnostics Market Overview
- North America Influenza Diagnostics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- North America Influenza Diagnostics Market Share & Forecast, 2016-2027
- By Test Type
- Traditional Diagnostic Tests
- RIDT
- Viral Culture
- DFA
- Serological Assays
- Molecular Diagnostic Tests
- RT-PCR
- Isothermal Nucleic Acid Amplification Tests
- Others
- Others
- Traditional Diagnostic Tests
- By End-User
- Hospital
- Clinical Laboratories
- Research Centers
- Point Of Care Testing Centers
- By Country
- US
- Canada
- Mexico
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on North America Influenza Diagnostics Market
- By Test Type
- Demand
- North America Influenza Diagnostics Market Size & Forecast, 2016-2027
- Europe Influenza Diagnostics Market Overview
- Europe Influenza Diagnostics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Europe Influenza Diagnostics Market Share & Forecast, 2016-2027
- By Test Type
- Traditional Diagnostic Tests
- RIDT
- Viral Culture
- DFA
- Serological Assays
- Molecular Diagnostic Tests
- RT-PCR
- Isothermal Nucleic Acid Amplification Tests
- Others
- Others
- Traditional Diagnostic Tests
- By End-User
- Hospital
- Clinical Laboratories
- Research Centers
- Point Of Care Testing Centers
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe Influenza Diagnostics Market
- By Test Type
- Demand
- Europe Influenza Diagnostics Market Size & Forecast, 2016-2027
- Asia Pacific Influenza Diagnostics Market Overview
- Asia Pacific Influenza Diagnostics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Asia Pacific Influenza Diagnostics Market Share & Forecast, 2016-2027
- By Test Type
- Traditional Diagnostic Tests
- RIDT
- Viral Culture
- DFA
- Serological Assays
- Molecular Diagnostic Tests
- RT-PCR
- Isothermal Nucleic Acid Amplification Tests
- Others
- Others
- Traditional Diagnostic Tests
- By End-User
- Hospital
- Clinical Laboratories
- Research Centers
- Point Of Care Testing Centers
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific Influenza Diagnostics Market
- By Test Type
- Demand
- Asia Pacific Influenza Diagnostics Market Size & Forecast, 2016-2027
- South America Influenza Diagnostics Market Overview
- South America Influenza Diagnostics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- South America Influenza Diagnostics Market Share & Forecast, 2016-2027
- By Test Type
- Traditional Diagnostic Tests
- RIDT
- Viral Culture
- DFA
- Serological Assays
- Molecular Diagnostic Tests
- RT-PCR
- Isothermal Nucleic Acid Amplification Tests
- Others
- Others
- Traditional Diagnostic Tests
- By End-User
- Hospital
- Clinical Laboratories
- Research Centers
- Point Of Care Testing Centers
- By Country
- Brazil
- Argentina
- Rest of South America
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on South America Influenza Diagnostics Market
- By Test Type
- Demand
- South America Influenza Diagnostics Market Size & Forecast, 2016-2027
- Middle East & Africa Influenza Diagnostics Market Overview
- Middle East & Africa Influenza Diagnostics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Middle East & Africa Influenza Diagnostics Market Share & Forecast, 2016-2027
- By Test Type
- Traditional Diagnostic Tests
- RIDT
- Viral Culture
- DFA
- Serological Assays
- Molecular Diagnostic Tests
- RT-PCR
- Isothermal Nucleic Acid Amplification Tests
- Others
- Others
- Traditional Diagnostic Tests
- By End-User
- Hospital
- Clinical Laboratories
- Research Centers
- Point Of Care Testing Centers
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Middle East & Africa Influenza Diagnostics Market
- By Test Type
- Demand
- Middle East & Africa Influenza Diagnostics Market Size & Forecast, 2016-2027
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Hoffmann-La Roche AG
- Quidel Corporation
- Thermo Fisher Scientific
- Abbott Laboratories
- Hologic
- Becton
- Dickinson, and Company
- DiaSorin S.p.A
- Luminex Corporation
- Meridian Bioscience
- GenMark Diagnostics
- SA Scientific
- Sekisui Diagnostics
- bioMérieux SA
- Danaher Corporation
- Siemens Healthineers
- Tecan Trading AG
- ELITech
- Mast Group,
- Other Prominent Players
